PROCEPT BioRobotics announced today that the first patients were treated in its WATER II Study, a clinical trial testing the safety and efficacy of Aquablation delivery by its surgical robotic AquaBeam System to treat benign prostatic hyperplasia.
The trials test the use of the system in prostates 80 to150 mL and will enroll 100 patients at up to 20 sites in the U.S. and Canada.
Read the full story on our sister site, The Robot Report.
The post PROCEPT BioRobotics treats first patients in WATER II test of surgical robot appeared first on MassDevice.
from MassDevice http://ift.tt/2yGXkhs
Cap comentari:
Publica un comentari a l'entrada